Suppr超能文献

基层和社区卫生保健中的初级卫生保健工作者:儿童消瘦的识别和治疗。

Lay health workers in primary and community health care for maternal and child health: identification and treatment of wasting in children.

机构信息

Norwegian Institute of Public Health, Oslo, Norway.

University of Washington, Seattle, Washington, USA.

出版信息

Cochrane Database Syst Rev. 2023 Aug 30;8(8):CD015311. doi: 10.1002/14651858.CD015311.

Abstract

BACKGROUND

Since the early 2010s, there has been a push to enhance the capacity to effectively treat wasting in children through community-based service delivery models and thus reduce morbidity and mortality.

OBJECTIVES

To assess the effectiveness of identification and treatment of moderate and severe wasting in children aged five years or under by lay health workers working in the community compared with health providers working in health facilities.

SEARCH METHODS

We searched MEDLINE, CENTRAL, two other databases, and two ongoing trials registers to 24 September 2021. We also screened the reference lists of related systematic reviews and all included studies.

SELECTION CRITERIA

We included randomised controlled trials (RCTs) and non-randomised studies in children aged five years or under with moderate wasting (defined as weight-for-height Z-score (WHZ) below -2 but no lower than ≥ -3, or mid-upper-arm circumference (MUAC) below 125 mm but no lower than 115 mm, and no nutritional oedema) or severe wasting (WHZ below -3 or MUAC below 115 mm or nutritional oedema). Eligible interventions were: • identification by lay health workers (LHWs) of children with wasting (intervention 1); • identification by LHWs of children with wasting and medical complications needing referral (intervention 2); and • identification by LHWs of children with wasting without medical complications needing referral (intervention 3). Eligible comparators were: • identification and treatment of wasting by health professionals such as nurses or doctors (at health facilities); and • identification and treatment of wasting by health facility-based teams, including health professionals and LHWs.

DATA COLLECTION AND ANALYSIS

Two review authors independently screened trials, extracted data and assessed risk of bias using the Cochrane risk of bias tool (RoB 2) and Cochrane Effective Practice and Organisation of Care (EPOC) guidelines. We used a random-effects model to meta-analyse data, producing risk ratios (RRs) for dichotomous outcomes in trials with individual allocation, adjusted RRs for dichotomous outcomes in trials with cluster allocation (using the generic inverse variance method in Review Manager 5), and mean differences (MDs) for continuous outcomes. We used the GRADE approach to assess the certainty of the evidence.

MAIN RESULTS

We included two RCTs and five non-RCTs. Six studies were from African countries, and one was from Pakistan. Six studies included children with severe wasting, and one included children with moderate wasting. All studies offered home-based ready-to-use therapeutic food treatment and monitoring. Children received antibiotics in three studies, vitamins or micronutrients in three studies, and deworming treatment in two studies. In three studies, the comparison arm involved LHWs screening children for malnutrition and referring them to health facilities for diagnosis and treatment. All the non-randomised studies had a high overall risk of bias. Interventions 1 and 2 Identification and referral for treatment by LHWs, compared with treatment by health professionals following self-referral, may result in little or no difference in the percentage of children who recover from moderate or severe wasting (MD 1.00%, 95% confidence interval (CI) -2.53 to 4.53; 1 RCT, 29,475 households; low certainty). Intervention 3 Compared with treatment by health professionals following identification by LHWs, identification and treatment of severe wasting in children by LHWs: • may slightly reduce improvement from severe wasting (RR 0.93, 95% CI 0.86 to 0.99; 1 RCT, 789 participants; low certainty); • may slightly increase non-response to treatment (RR 1.44, 95% CI 1.04 to 2.01; 1 RCT, 789 participants; low certainty); • may result in little or no difference in the number of children with WHZ above -2 on discharge (RR 0.94, 95% CI 0.28 to 3.18; 1 RCT, 789 participants; low certainty); • probably results in little or no difference in the number of children with WHZ between -3 and -2 on discharge (RR 1.09, 95% CI 0.87 to 1.36; 1 RCT, 789 participants; moderate certainty); • probably results in little or no difference in the number of children with WHZ below -3 (severe wasting) on discharge (RR 1.23, 95% CI 0.75 to 2.04; 1 RCT, 789 participants; moderate certainty); • probably results in little or no difference in the number of children with MUAC equal to or greater than 115 mm on discharge (RR 0.99, 95% CI 0.93 to 1.06; 1 RCT, 789 participants; moderate certainty); • results in little or no difference in weight gain per day (mean weight gain 0.50 g/kg/day higher, 95% CI 1.74 lower to 2.74 higher; 1 RCT, 571 participants; high certainty); • probably has little or no effect on relapse of severe wasting (RR 1.03, 95% CI 0.69 to 1.54; 1 RCT, 649 participants; moderate certainty); • may have little or no effect on mortality among children with severe wasting (RR 0.46, 95% CI 0.04 to 5.98; 1 RCT, 829 participants; low certainty); • probably has little or no effect on the transfer of children with severe wasting to inpatient care (RR 3.71, 95% CI 0.36 to 38.23; 1 RCT, 829 participants; moderate certainty); and • probably has little or no effect on the default of children with severe wasting (RR 1.48, 95% CI 0.65 to 3.40; 1 RCT, 829 participants; moderate certainty). The evidence was very uncertain for total MUAC gain, MUAC gain per day, total weight gain, treatment coverage, and transfer to another LHW site or health facility. No studies examined sustained recovery, deterioration to severe wasting, appropriate identification of children with wasting or oedema, appropriate referral of children with moderate or severe wasting, adherence, or adverse effects and other harms.

AUTHORS' CONCLUSIONS: Identification and treatment of severe wasting in children who do not require inpatient care by LHWs, compared with treatment by health professionals, may lead to similar or slightly poorer outcomes. We found only two RCTs, and the evidence from non-randomised studies was of very low certainty for all outcomes due to serious risks of bias and imprecision. No studies included children aged under 6 months. Future studies must address these methodological issues.

摘要

背景

自 21 世纪 10 年代初以来,人们一直致力于通过以社区为基础的服务模式提高有效治疗儿童消瘦的能力,从而降低发病率和死亡率。

目的

评估在社区工作的初级卫生保健工作者与在卫生机构工作的卫生保健提供者相比,识别和治疗五岁以下儿童中度和重度消瘦的效果。

检索方法

我们检索了 MEDLINE、CENTRAL、另外两个数据库和两个正在进行的试验登记处,检索时间截至 2021 年 9 月 24 日。我们还筛选了相关系统评价和所有纳入研究的参考文献列表。

选择标准

我们纳入了随机对照试验(RCTs)和社区中五岁以下儿童中度消瘦(定义为体重身高 Z 评分(WHZ)低于-2 但不低于≥-3,或中上臂围(MUAC)低于 125 毫米但不低于 115 毫米,且无营养性水肿)或重度消瘦(WHZ 低于-3 或 MUAC 低于 115 毫米或营养性水肿)的 RCTs 和非随机研究。符合条件的干预措施包括:1. 初级卫生保健工作者(LHWs)识别消瘦儿童(干预 1);2. LHWs 识别消瘦并需要转诊的儿童有医疗并发症(干预 2);3. LHWs 识别消瘦但无医疗并发症需要转诊的儿童(干预 3)。符合条件的对照组包括:1. 卫生专业人员(如护士或医生)在卫生机构中识别和治疗消瘦;2. 卫生机构为基础的团队在卫生机构中识别和治疗消瘦,包括卫生专业人员和 LHWs。

数据收集和分析

两名综述作者独立筛选试验、提取数据并使用 Cochrane 偏倚风险工具(RoB 2)和 Cochrane 有效实践和组织护理(EPOC)指南评估风险偏倚。我们使用随机效应模型对数据进行荟萃分析,为个体分配的试验产生二分类结局的风险比(RR),为聚类分配的试验产生二分类结局的调整 RR(使用 Review Manager 5 中的通用倒数方差法),以及连续结局的平均差异(MD)。我们使用 GRADE 方法评估证据的确定性。

主要结果

我们纳入了两项 RCT 和五项非 RCT。六项研究来自非洲国家,一项来自巴基斯坦。六项研究包括严重消瘦的儿童,一项包括中度消瘦的儿童。所有研究都提供了家庭用即食治疗性食品治疗和监测。三项研究中儿童接受了抗生素治疗,三项研究中接受了维生素或微量营养素治疗,两项研究中接受了驱虫治疗。在三项研究中,比较组涉及 LHW 筛查营养不良并将其转诊至卫生机构进行诊断和治疗。所有非随机研究都存在高总体偏倚风险。干预 1 和 2 与健康专业人员自行转诊后治疗相比,LHW 对消瘦儿童进行识别和转诊治疗,可能导致中度或重度消瘦儿童康复的比例没有差异或略有差异(MD 1.00%,95%置信区间(CI)-2.53 至 4.53;1 项 RCT,29475 户家庭;低确定性)。干预 3 与 LHW 识别并治疗严重消瘦的儿童相比,LHW 识别和治疗儿童严重消瘦:1. 可能轻微降低从严重消瘦中恢复的比例(RR 0.93,95%CI 0.86 至 0.99;1 项 RCT,789 名参与者;低确定性);2. 可能轻微增加无反应治疗的比例(RR 1.44,95%CI 1.04 至 2.01;1 项 RCT,789 名参与者;低确定性);3. 可能导致出院时体重身高 Z 评分(WHZ)大于 2 的儿童比例无差异或略有差异(RR 0.94,95%CI 0.28 至 3.18;1 项 RCT,789 名参与者;低确定性);4. 可能导致出院时 WHZ 在-3 和-2 之间的儿童比例无差异或略有差异(RR 1.09,95%CI 0.87 至 1.36;1 项 RCT,789 名参与者;中等确定性);5. 可能导致出院时 WHZ 低于-3(严重消瘦)的儿童比例无差异或略有差异(RR 1.23,95%CI 0.75 至 2.04;1 项 RCT,789 名参与者;中等确定性);6. 可能导致出院时 MUAC 等于或大于 115 毫米的儿童比例无差异或略有差异(RR 0.99,95%CI 0.93 至 1.06;1 项 RCT,789 名参与者;中等确定性);7. 可能导致体重每天增加量无差异(平均体重增加 0.50g/kg/天更高,95%CI 1.74 天更低至 2.74 天更高;1 项 RCT,571 名参与者;高确定性);8. 可能对严重消瘦的复发率没有影响(RR 1.03,95%CI 0.69 至 1.54;1 项 RCT,649 名参与者;中等确定性);9. 可能对严重消瘦儿童的死亡率没有影响(RR 0.46,95%CI 0.04 至 5.98;1 项 RCT,829 名参与者;低确定性);10. 可能对严重消瘦儿童转入住院治疗没有影响(RR 3.71,95%CI 0.36 至 38.23;1 项 RCT,829 名参与者;中等确定性);11. 可能对严重消瘦儿童的默认治疗没有影响(RR 1.48,95%CI 0.65 至 3.40;1 项 RCT,829 名参与者;中等确定性)。MUAC 总增益、MUAC 每日增益、总体重增益、治疗覆盖率以及转移到另一个 LHW 站点或卫生机构的治疗覆盖范围的证据非常不确定。没有研究评估持续恢复、恶化至严重消瘦、消瘦或水肿儿童的适当识别、中度或重度消瘦儿童的适当转诊、依从性或不良反应和其他危害。

作者结论

与由卫生专业人员治疗相比,LHW 对不需要住院治疗的严重消瘦儿童进行识别和治疗,可能导致类似或稍差的结局。我们只发现了两项 RCT,由于严重偏倚和不精确性,所有结局的非随机研究证据的确定性都很低。没有研究包括 6 个月以下的儿童。未来的研究必须解决这些方法学问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e9/10467022/eac3942403a0/tCD015311-FIG-01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验